JANE STREET GROUP, LLC - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 35 filers reported holding APREA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$16,864
-68.8%
50,950
-29.2%
0.00%
Q2 2022$54,000
-11.5%
71,959
+239.4%
0.00%
Q4 2021$61,000
-76.6%
21,202
-58.5%
0.00%
Q3 2021$261,000
+350.0%
51,059
+330.7%
0.00%
Q4 2020$58,00011,8560.00%
Other shareholders
APREA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Crestline Management, LP 48,819$36,0000.01%
Quantamental Technologies LLC 11,352$9,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 45,000$33,0000.00%
Tower Research Capital LLC (TRC) 47,362$36,0000.00%
Virtu Financial LLC 19,664$15,0000.00%
Sugarloaf Wealth Management, LLC 5,000$4,0000.00%
Bank of New York Mellon Corp 16,643$12,0000.00%
Blackstone Inc. 16,590$12,0000.00%
Citadel Advisors 365,900$271,0000.00%
Citadel Advisors 12,000$9,0000.00%
View complete list of APREA THERAPEUTICS INC shareholders